{"content":"<li class=\"n-box-item date-title\" data-end=\"1375329599\" data-start=\"1375243200\" data-txt=\"Friday, December 20, 2019\">Wednesday, July 31, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1182572\" data-ts=\"1375326898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182572-shanghai-tokyo-move-higher-after-fed-china-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shanghai, Tokyo move higher after Fed, China data</a></h4><ul>     <li>The Shanghai Composite rises <font color=\"green\">1.3%</font> following a better than expected <a href=\"https://seekingalpha.com/currents/post/1182562\" target=\"_blank\">official PMI</a> print. The Hang Seng is up <font color=\"green\">1%</font>.</li>     <li>The Nikkei jumps <font color=\"green\">1.16%</font> as the yen falls <font color=\"red\">0.3%</font> against the dollar to ¥98.18.</li>     <li>Not along for the ride are Australian equities, which are off <font color=\"red\">0.3%</font> in Sydney. The aussie trades near a three-year low sliding <font color=\"red\">0.26%</font> to 0.8957. </li> </ul><div class=\"tiny-share-widget\" data-id=\"1182572\" data-linked=\"Shanghai, Tokyo move higher after Fed, China data\" data-tweet=\"Shanghai, Tokyo move higher after Fed, China data https://seekingalpha.com/news/1182572-shanghai-tokyo-move-higher-after-fed-china-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1182572-shanghai-tokyo-move-higher-after-fed-china-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182542\" data-ts=\"1375315750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPC\" target=\"_blank\">PPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182542-more-on-pilgrims-pride-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Pilgrims Pride earnings</a></h4><ul>\n<li>Pilgrim's Pride (NYSE:<a href=\"https://seekingalpha.com/symbol/PPC\" title=\"Pilgrim's Pride Corporation\">PPC</a>) <a href=\"https://seekingalpha.com/market_currents/post/1182402\" target=\"_blank\">Q2 comes in line</a> on revenue but beats on a per share basis.</li>\n<li>Net profit more than doubled as gross margins widened to 12.9% from 7.3%, boosted by sales improvements that outpaced growth in input costs.</li>\n<li>Shares <font color=\"green\">+1.8%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1182542\" data-linked=\"More on Pilgrims Pride earnings\" data-tweet=\"$PPC - More on Pilgrims Pride earnings https://seekingalpha.com/news/1182542-more-on-pilgrims-pride-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1182542-more-on-pilgrims-pride-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182522\" data-ts=\"1375312601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182522-sandisk-initiates-0_225-share-dividend-adds-2_5b-to-buyback-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SanDisk initiates $0.225/share dividend, adds $2.5B to buyback plan</a></h4><ul>     <li>The quarterly dividend is good for a 1.6% yield.</li>     <li>$1B of the $2.5B in buybacks will take place via an accelerated repurchase program with an unnamed financial institution.</li>     <li>Excluding the program, and including funds remaining on an existing $1.25B authorization, SanDisk has $2.1B in available buyback funds, good for repurchasing 15% of outstanding shares at current levels.</li>     <li>SNDK <font color=\"green\">+4.4%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1182522\" data-linked=\"SanDisk initiates $0.225/share dividend, adds $2.5B to buyback plan\" data-tweet=\"$WDC - SanDisk initiates $0.225/share dividend, adds $2.5B to buyback plan https://seekingalpha.com/news/1182522-sandisk-initiates-0_225-share-dividend-adds-2_5b-to-buyback-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/1182522-sandisk-initiates-0_225-share-dividend-adds-2_5b-to-buyback-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182492\" data-ts=\"1375312222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182492-sunpower-reverses-course-now-minus-2_6-percent-ah-on-mixed-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunPower reverses course, now -2.6% AH on mixed Q2, guidance</a></h4><ul>     <li>SunPower's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a>) Q2 EPS beat had much to do with a gross margin of 19.5%, -320 bps Q/Q but +480 bps Y/Y and well above guidance of 14%-16%. SunPower attributes the gains to cost reductions.</li>     <li>Full-year GM guidance is now at 18%-20%, above a prior 15%-17%. Q3 GM guidance of 17%-19%.</li>     <li>SunPower still expects to recognize 1GW-1.1GW in module shipments in 2013. 277MW were recognized in Q2, near the high end of a guidance range of 260MW-280MW. 240MW-260MW expected in Q3.</li>     <li>Q2 Americas sales (68% of revenue) -1% Y/Y. EMEA -31%. Asia-Pac +110%, thanks in part to 30% Q/Q growth in Japan.</li>     <li>Americas GM was 22.5% in Q2, -1000 bps Q/Q and +340 bps Y/Y. EMEA GM was 9.7% after being negative for three straight quarters. Asia-Pac came in at 16.6%.</li>     <li>All of SunPower's plants are running at 100% utilization.</li>     <li>Shares <strong><font color=\"green\">+391%</font></strong> YTD going into the report.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1181012\" target=\"_blank\">Q2 results</a>, PR, <a href=\"http://files.shareholder.com/downloads/SPWR/2613147779x0x680916/a5382894-95c5-4749-bfb8-631473d545d7/Q2%202013%20Supplementary%20Slides.pdf\" target=\"_blank\">slides</a>, <a href=\"http://files.shareholder.com/downloads/SPWR/2613147779x0x680914/9df2595f-609f-4541-a713-659e8e7efc75/Q2%202013%20Supplementary%20Metric%20Sheet%20Final.pdf\" target=\"_blank\">datasheet</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1182492\" data-linked=\"SunPower reverses course, now -2.6% AH on mixed Q2, guidance\" data-tweet=\"$SPWR - SunPower reverses course, now -2.6% AH on mixed Q2, guidance https://seekingalpha.com/news/1182492-sunpower-reverses-course-now-minus-2_6-percent-ah-on-mixed-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1182492-sunpower-reverses-course-now-minus-2_6-percent-ah-on-mixed-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182322\" data-ts=\"1375309266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182322-more-on-cbs-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on CBS earnings</a></h4><ul>\n<li>CBS (NYSE:<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a>) <a href=\"https://seekingalpha.com/market_currents/post/1180842\" target=\"_blank\">Q2 beats</a> on all counts as total revenue rises by 11% Y/Y.</li>\n<li>Net profit also rose 10.5%, boosted by digital streaming and international syndication deals, higher fees paid by pay TV operators to carry CBS-owned TV stations as well as sports programming.</li>\n<li>Advertising revenue, which contributes more than half of the company's top line, grew 4.7% to $2.09B, lifted by higher advertising revenue from the NCAA Men's Basketball Championship semifinals.</li>\n<li>Shares <font color=\"green\">+1.2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1182322\" data-linked=\"More on CBS earnings\" data-tweet=\"$CBS $VIAC - More on CBS earnings https://seekingalpha.com/news/1182322-more-on-cbs-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1182322-more-on-cbs-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182302\" data-ts=\"1375308980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRP\" target=\"_blank\">CTRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182302-ctrip-com-beats-by-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ctrip.com beats by $0.07, beats on revenue</a></h4><ul>     <li>Ctrip.com (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTRP\" title=\"Ctrip.com International, Ltd.\">CTRP</a>): Q2 EPS of $0.36 <font color=\"green\">beats by $0.07</font>.</li>\n<li>Revenue of $203M <font color=\"green\">beats by $12.59M</font>. Shares  <font color=\"green\">+1.6%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1182302\" data-linked=\"Ctrip.com beats by $0.07, beats on revenue\" data-tweet=\"$CTRP $TCOM - Ctrip.com beats by $0.07, beats on revenue https://seekingalpha.com/news/1182302-ctrip-com-beats-by-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1182302-ctrip-com-beats-by-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182292\" data-ts=\"1375308849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DX\" target=\"_blank\">DX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182292-dynex-capital-beats-by-0_22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynex Capital beats by $0.22</a></h4><ul>     <li>Dynex Capital (NYSE:<a href=\"https://seekingalpha.com/symbol/DX\" title=\"Dynex Capital Inc.\">DX</a>): Q2 EPS of $0.54 <font color=\"green\">beats by $0.22</font>. Shares  <font color=\"red\">-9.6%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1182292\" data-linked=\"Dynex Capital beats by $0.22\" data-tweet=\"$DX - Dynex Capital beats by $0.22 https://seekingalpha.com/news/1182292-dynex-capital-beats-by-0_22?source=tweet\" data-url=\"https://seekingalpha.com/news/1182292-dynex-capital-beats-by-0_22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182162\" data-ts=\"1375308009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROVI\" target=\"_blank\">ROVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182162-rovi-minus-4_4-percent-ah-due-to-revenue-miss-guidance-company-selling-2-businesses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rovi -4.4% AH due to revenue miss, guidance; company selling 2 businesses</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/symbol/ROVI\" title=\"Rovi Corporation\">ROVI</a> has reached deals to sell its struggling Entertainment Store (private-label digital content sales) and Consumer Website businesses. The former has been <a href=\"https://seekingalpha.com/currents/post/744991\" target=\"_blank\">on the block</a> since January.</li>\n<li>Rovi now expects 2013 revenue of $600M-$630M and EPS of $1.80-$2.10, below a prior forecast of $630M-$660M, and largely below consensus of $645.4M and $2.09.</li>\n<li>The Consumer Website sale has a $7M-$9M impact on revenue guidance. For the rest, Rovi blames \"uncertainties with respect to the timing of closing several new [licensing] agreements\" with international and over-the-top (i.e. Internet video) companies. Rovi remains mired in <a href=\"https://seekingalpha.com/currents/post/1074382\" target=\"_blank\">a legal battle</a> with Netflix and Roku.</li>\n<li>Revenue -5% Y/Y in Q2. Service provider revenue +10% to $83.7M, but consumer electronics businesses -27% $47.3M.</li>\n<li>$65M was spent on buybacks in Q2.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1181322\" target=\"_blank\">Q2 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1182162\" data-linked=\"Rovi -4.4% AH due to revenue miss, guidance; company selling 2 businesses\" data-tweet=\"$ROVI - Rovi -4.4% AH due to revenue miss, guidance; company selling 2 businesses https://seekingalpha.com/news/1182162-rovi-minus-4_4-percent-ah-due-to-revenue-miss-guidance-company-selling-2-businesses?source=tweet\" data-url=\"https://seekingalpha.com/news/1182162-rovi-minus-4_4-percent-ah-due-to-revenue-miss-guidance-company-selling-2-businesses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182022\" data-ts=\"1375306825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182022-lam-research-minus-2_4-percent-ah-thanks-to-light-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lam Research -2.4% AH thanks to light guidance</a></h4><ul>\n<li>Though Lam's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LRCX\" title=\"Lam Research Corporation\">LRCX</a>) FQ4 results beat estimates, the chip equipment maker expects FQ1 revenue of $1B (+/- $30M) and EPS of $0.68 (+/- $0.07), which is unfavorable to a consensus of $1.04B and $0.83.</li>\n<li>FQ1 shipments are also expected to total $1B (+/- $30M).</li>\n<li>FQ4 gross margin +60 bps Q/Q to 43.5%, deferred revenue +19% Q/Q to $389.2M. FQ1 gross margin guidance of 44% (+/- 1%).</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1181092\" target=\"_blank\">FQ4 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1182022\" data-linked=\"Lam Research -2.4% AH thanks to light guidance\" data-tweet=\"$LRCX - Lam Research -2.4% AH thanks to light guidance https://seekingalpha.com/news/1182022-lam-research-minus-2_4-percent-ah-thanks-to-light-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1182022-lam-research-minus-2_4-percent-ah-thanks-to-light-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1182012\" data-ts=\"1375306762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STMP\" target=\"_blank\">STMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1182012-stamps-com-beats-by-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stamps.com beats by $0.13, beats on revenue</a></h4><ul>     <li>Stamps.com (NASDAQ:<a href=\"https://seekingalpha.com/symbol/STMP\" title=\"Stamps.com Inc.\">STMP</a>): Q2 EPS of $0.60 <font color=\"green\">beats by $0.13</font>.</li>\n<li>Revenue of $32.1M (+14% Y/Y) <font color=\"green\">beats by $0.65M</font>. Shares  <font color=\"green\">+7.7%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1182012\" data-linked=\"Stamps.com beats by $0.13, beats on revenue\" data-tweet=\"$STMP - Stamps.com beats by $0.13, beats on revenue https://seekingalpha.com/news/1182012-stamps-com-beats-by-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1182012-stamps-com-beats-by-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181992\" data-ts=\"1375306634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DX\" target=\"_blank\">DX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181992-dynex-book-value-sinks-14_9-percent-in-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynex book value sinks 14.9% in Q2</a></h4><ul>     <li>Book value per share declines 14.9% to $8.94.</li>     <li>EPS of $29.4M or $0.54/share includes fair value adjustments (related to long-term rate swaps not subject to hedge accounting) of $10.7M or $0.20/share. Backing that out brings EPS to a more inline $0.34.</li>     <li>Net interest spread of 1.75% vs. 1.89% in Q1.</li>     <li>Leverage increases to 6.8x from 6.3x.</li>     <li>CPR of 21% vs. 19.3% in Q1, 14.3% a year ago.</li>     <li>Management notes it wasn't so much the rise in interest rates during the quarter as it was the widening in credit spreads, meaning hybrid REITs (see <a href=\"https://seekingalpha.com/currents/post/1180922\" target=\"_blank\">Invesco earlier</a>) had no advantage over their agency brethren when it came to preserving book value.</li>     <li>\n<a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dynexcapital.com&amp;esheet=50682557&amp;newsitemid=20130731006760&amp;lan=en-US&amp;anchor=www.dynexcapital.com&amp;index=1&amp;md5=08377cf97980bc88f9b33078ae8a25cf\" target=\"_blank\">Earnings call</a> at at 11 ET. (PR)</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/DX\" title=\"Dynex Capital Inc.\">DX</a> <font color=\"red\">-9.4%</font> AH to $8.71.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181992\" data-linked=\"Dynex book value sinks 14.9% in Q2\" data-tweet=\"$DX - Dynex book value sinks 14.9% in Q2 https://seekingalpha.com/news/1181992-dynex-book-value-sinks-14_9-percent-in-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/1181992-dynex-book-value-sinks-14_9-percent-in-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181962\" data-ts=\"1375306447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181962-more-on-sturm-ruger-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sturm Ruger earnings</a></h4><ul>\n<li>Sturm, Ruger (NYSE:<a href=\"https://seekingalpha.com/symbol/RGR\" title=\"Sturm, Ruger &amp; Company Inc.\">RGR</a>) <a href=\"https://seekingalpha.com/market_currents/post/1181812\" target=\"_blank\">Q2 beats</a> across the board.</li>\n<li>Net earnings increased 79%, driven by 50% growth in sales and ongoing focus on improvement in operations.</li>\n<li>New product introductions, including the LC380 and SR45 pistols, were a significant component of sales growth, representing 31% of firearm sales in the first half of 2013.</li>\n<li>Estimated unit sell-through of products from the independent distributors to retailers increased 37 from comparable prior year periods.</li>\n<li>Shares <font color=\"green\">+5.2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1181962\" data-linked=\"More on Sturm Ruger earnings\" data-tweet=\"$RGR - More on Sturm Ruger earnings https://seekingalpha.com/news/1181962-more-on-sturm-ruger-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1181962-more-on-sturm-ruger-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181942\" data-ts=\"1375306395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGEN\" target=\"_blank\">SGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181942-seattle-genetics-reports-q2-results-adcetris-sales-tick-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seattle Genetics reports Q2 results, Adcetris sales tick higher</a></h4><ul>     <li>Seattle Genetics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SGEN\" title=\"Seattle Genetics, Inc.\">SGEN</a>) <a href=\"https://seekingalpha.com/currents/post/1180992\" target=\"_blank\">Q2 results</a> top estimates.</li>     <li>Adcetris sales for the period were <em>$35.7M</em>. That's up slightly from Q2 2012 sales of $34.7M and Q1 sales of $33.9M. Consensus was $34.2M. (PR)</li>     <li>Shares <font color=\"red\">-2.44%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181942\" data-linked=\"Seattle Genetics reports Q2 results, Adcetris sales tick higher\" data-tweet=\"$SGEN - Seattle Genetics reports Q2 results, Adcetris sales tick higher https://seekingalpha.com/news/1181942-seattle-genetics-reports-q2-results-adcetris-sales-tick-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1181942-seattle-genetics-reports-q2-results-adcetris-sales-tick-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181932\" data-ts=\"1375306239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181932-after-hours-top-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers / Losers</a></h4><ul>     <li><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/RKUS' title='Ruckus Wireless'>RKUS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AFFX' title='Affymetrix, Inc.'>AFFX</a> <font color='green'>+8%</font>. TRLA <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/THOR-OLD' title='Thoratec Corporation'>THOR-OLD</a> <font color='green'>+8%</font>.</li><li><b>&nbsp;losers:</b> <a href='https://seekingalpha.com/symbol/GRMN' title='Garmin Ltd.'>GRMN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TBBK' title='The Bancorp, Inc.'>TBBK</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica'>SLCA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ROVI' title='Rovi Corporation'>ROVI</a> <font color='red'>-4%</font>. CAVM <font color='red'>-4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181932\" data-linked=\"After-hours top gainers / Losers\" data-tweet=\"$RKUS $STMP $AFFX - After-hours top gainers / Losers https://seekingalpha.com/news/1181932-after-hours-top-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1181932-after-hours-top-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181862\" data-ts=\"1375305956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PXD\" target=\"_blank\">PXD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181862-pioneer-natural-resources-pops-10-points-ah-following-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pioneer Natural Resources pops 10 points AH following earnings</a></h4><ul>     <li>Pioneer Natural Resources' (NYSE:<a href=\"https://seekingalpha.com/symbol/PXD\" title=\"Pioneer Natural Resources Company\">PXD</a>) <a href=\"https://seekingalpha.com/currents/post/1181212\" target=\"_blank\">Q2 earnings</a> fell short of estimates, but oil and gas revenue rose 31.7% Y/Y to $845M.</li>\n<li>Production grew 3%; average prices rose 13%, including 2.8% growth for oil and 87% for natural gas that offset a 14% decline for natural gas liquids.</li>\n<li>Q3 production is forecast to average 174M-179M boe/day, assuming output in the Spraberry/Wolfcamp area will be negatively impacted by~2M boe/day from ethane rejection due to low ethane prices; production costs are expected to average $14-$16/boe.</li>          <li>Shares <font color=\"green\">+6%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181862\" data-linked=\"Pioneer Natural Resources pops 10 points AH following earnings\" data-tweet=\"$PXD - Pioneer Natural Resources pops 10 points AH following earnings https://seekingalpha.com/news/1181862-pioneer-natural-resources-pops-10-points-ah-following-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1181862-pioneer-natural-resources-pops-10-points-ah-following-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181762\" data-ts=\"1375304936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLCA\" target=\"_blank\">SLCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181762-u-s-silica-misses-by-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Silica misses by $0.02, misses on revenue</a></h4><ul>     <li>U.S. Silica (NYSE:<a href=\"https://seekingalpha.com/symbol/SLCA\" title=\"U.S. Silica\">SLCA</a>): Q2 EPS of $0.38 <font color=\"red\">misses by $0.02</font>.</li>\n<li>Revenue of $129.8M (+24% Y/Y) <font color=\"red\">misses by $4.77M</font>. Shares  <font color=\"red\">-9.1%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181762\" data-linked=\"U.S. Silica misses by $0.02, misses on revenue\" data-tweet=\"$SLCA - U.S. Silica misses by $0.02, misses on revenue https://seekingalpha.com/news/1181762-u-s-silica-misses-by-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181762-u-s-silica-misses-by-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181702\" data-ts=\"1375304576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAM\" target=\"_blank\">SAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181702-boston-beer-tops-estimates-lifts-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Beer tops estimates, lifts guidance</a></h4><ul>     <li>Boston Beer (NYSE:<a href=\"https://seekingalpha.com/symbol/SAM\" title=\"Boston Beer Co.\">SAM</a>) <a href=\"https://seekingalpha.com/currents/post/1181172\" target=\"_blank\">beats</a> on the top and bottom line.</li>     <li>Core shipment growth of 21% Y/Y. Depletions growth comes in at 24%.</li>     <li>Gross margin of 54%. (PR)</li>     <li>FY13 outlook is raised: Depletions growth of 17-22% (from 10-15%), EPS of $5.10-5.40 (from $4.70-5.10), capex of $100-140M (from $85-105M).</li>     <li>Shares <font color=\"green\">+5%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181702\" data-linked=\"Boston Beer tops estimates, lifts guidance\" data-tweet=\"$SAM - Boston Beer tops estimates, lifts guidance https://seekingalpha.com/news/1181702-boston-beer-tops-estimates-lifts-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1181702-boston-beer-tops-estimates-lifts-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181682\" data-ts=\"1375304537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTEX\" target=\"_blank\">OTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181682-open-text-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Open Text EPS in-line, misses on revenue</a></h4><ul>     <li>Open Text (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OTEX\" title=\"Open Text Corporation\">OTEX</a>): FQ4 EPS of $1.43 in-line.</li>\n<li>Revenue of $347.3M (+14% Y/Y) <font color=\"red\">misses by $13.75M</font>. Shares  <font color=\"red\">-5.7%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181682\" data-linked=\"Open Text EPS in-line, misses on revenue\" data-tweet=\"$OTEX - Open Text EPS in-line, misses on revenue https://seekingalpha.com/news/1181682-open-text-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181682-open-text-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181482\" data-ts=\"1375303738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBMD\" target=\"_blank\">WBMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181482-webmd-misses-by-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WebMD misses by $0.01, beats on revenue</a></h4><ul>     <li>WebMD (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WBMD\" title=\"WebMD Health Corp\">WBMD</a>): Q2 EPS of $0.05 <font color=\"red\">misses by $0.01</font>.</li>\n<li>Revenue of $125.3M <font color=\"green\">beats by $0.9M</font>. Shares  <font color=\"red\">-1.9%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181482\" data-linked=\"WebMD misses by $0.01, beats on revenue\" data-tweet=\"$WBMD - WebMD misses by $0.01, beats on revenue https://seekingalpha.com/news/1181482-webmd-misses-by-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181482-webmd-misses-by-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181402\" data-ts=\"1375303354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFLY\" target=\"_blank\">SFLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181402-shutterfly-beats-by-0_26-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shutterfly beats by $0.26, beats on revenue</a></h4><ul>     <li>Shutterfly (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SFLY\" title=\"Shutterfly, Inc.\">SFLY</a>): Q2 EPS of -$0.29 <font color=\"green\">beats by $0.26</font>.</li>     <li>Revenue of $133.5M (+35% Y/Y) <font color=\"green\">beats by $11.5M</font>. Shares  <font color=\"green\">+2.6%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181402\" data-linked=\"Shutterfly beats by $0.26, beats on revenue\" data-tweet=\"$SFLY - Shutterfly beats by $0.26, beats on revenue https://seekingalpha.com/news/1181402-shutterfly-beats-by-0_26-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181402-shutterfly-beats-by-0_26-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181352\" data-ts=\"1375303072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181352-trulia-beats-by-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trulia beats by $0.01, beats on revenue</a></h4><ul>     <li>Trulia (TRLA): Q2 EPS of $0.05 <font color=\"green\">beats by $0.01</font>.</li>\n<li>Revenue of $29.7M (+77% Y/Y) <font color=\"green\">beats by $2.01M</font>. Shares  <font color=\"green\">+9.9%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181352\" data-linked=\"Trulia beats by $0.01, beats on revenue\" data-tweet=\"$Z - Trulia beats by $0.01, beats on revenue https://seekingalpha.com/news/1181352-trulia-beats-by-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181352-trulia-beats-by-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181342\" data-ts=\"1375303023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYC\" target=\"_blank\">PCYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181342-pharmacyclics-tops-estimates-for-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharmacyclics tops estimates for Q2</a></h4><ul>     <li>Pharmacyclics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a>) Q2 comes in <a href=\"https://seekingalpha.com/currents/post/1180892\" target=\"_blank\">ahead of Street estimates</a>.</li>     <li>Shares <font color=\"green\">+2.18%</font> AH.</li>     <li>Revenue of $54.2M is primarily attributable to a $50M milestone payment (from Janssen) tied to the enrollment of a fifth patient in a trial testing <a href=\"https://seekingalpha.com/currents/search?query=ibrutinib\" target=\"_blank\">ibrutinib</a> for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma.That's the fourth such payment to date.</li>\n<li>PCYC recognized a $17.4M reduction in R&amp;D expense for the quarter due to its capped development cost deal with Janssen. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181342\" data-linked=\"Pharmacyclics tops estimates for Q2\" data-tweet=\"$PCYC - Pharmacyclics tops estimates for Q2 https://seekingalpha.com/news/1181342-pharmacyclics-tops-estimates-for-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/1181342-pharmacyclics-tops-estimates-for-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181232\" data-ts=\"1375302620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKUS\" target=\"_blank\">RKUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181232-ruckus-plus-10_1-percent-ah-thanks-to-q2-beat-in-line-guidance-low-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ruckus +10.1% AH thanks to Q2 beat, in-line guidance, low expectations</a></h4><ul>     <li>Ruckus' (NYSE:<a href=\"https://seekingalpha.com/symbol/RKUS\" title=\"Ruckus Wireless\">RKUS</a>) Q3 guidance is for revenue of $66M-$69M and EPS of $0.04 vs. a consensus of $67.6M and $0.04.</li>     <li>Q2 beat fueled by 62% Y/Y EMEA growth. Americas +31%.</li>     <li>2.9K new enterprise end-customers added.</li>     <li>Shares were crushed in May thanks to a <a href=\"https://seekingalpha.com/currents/post/1001651\" target=\"_blank\">Q1 miss</a> and <a href=\"https://seekingalpha.com/currents/post/1001911\" target=\"_blank\">light guidance</a>, leaving investor expectations low.</li>     <li>Piper's <a href=\"https://seekingalpha.com/currents/post/1117952\" target=\"_blank\">bullish coverage launch</a> and Needham's <a href=\"https://seekingalpha.com/currents/post/1054511\" target=\"_blank\">upgrade</a> look smart.</li>     <li>CC at 5PM ET (<a href=\"http://investors.ruckuswireless.com/phoenix.zhtml?p=irol-eventDetails&amp;c=251538&amp;eventID=4986766\" target=\"_blank\">webcast</a>)</li>     <li>Enterprise/carrier Wi-Fi rival Aruba (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARUN\" title=\"Aruba Networks, Inc.\">ARUN</a>), whose shares have also plunged, is <font color=\"green\">up 0.7%</font>.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1180962\" target=\"_blank\">Q2 results</a>, PR</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181232\" data-linked=\"Ruckus +10.1% AH thanks to Q2 beat, in-line guidance, low expectations\" data-tweet=\"$RKUS $RKUS $ARUN - Ruckus +10.1% AH thanks to Q2 beat, in-line guidance, low expectations https://seekingalpha.com/news/1181232-ruckus-plus-10_1-percent-ah-thanks-to-q2-beat-in-line-guidance-low-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/1181232-ruckus-plus-10_1-percent-ah-thanks-to-q2-beat-in-line-guidance-low-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181222\" data-ts=\"1375302616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUIK\" target=\"_blank\">QUIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181222-quicklogic-beats-by-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuickLogic beats by $0.01, beats on revenue</a></h4><ul>     <li>QuickLogic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QUIK\" title=\"QuickLogic Corporation\">QUIK</a>): Q2 EPS of -$0.05 <font color=\"green\">beats by $0.01</font>.</li>\n<li>Revenue of $5.1M (+26% Y/Y) <font color=\"green\">beats by $0.8M</font>. Shares  <font color=\"green\">+3.6%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181222\" data-linked=\"QuickLogic beats by $0.01, beats on revenue\" data-tweet=\"$QUIK - QuickLogic beats by $0.01, beats on revenue https://seekingalpha.com/news/1181222-quicklogic-beats-by-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181222-quicklogic-beats-by-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181162\" data-ts=\"1375302126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181162-yelps-q3-2013-guidance-strong-shares-plus-5-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp&#39;s Q3/2013 guidance strong, shares +5% AH</a></h4><ul>\n<li>Yelp (NYSE:<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a>) expects Q3 revenue of $58M-$59M, above a $57.4M consensus.</li>\n<li>2013 guidance is for revenue of $222M-$224M and adjusted EBITDA of $27M-$28M, above prior guidance of $216M-$218M and $21M-$23M. Revenue consensus is at $220M.</li>\n<li>Cumulative reviews +41% Y/Y to 42.5M (+42% in Q1), average monthly unique visitors +38% to 108M (+43% prior), active local business accounts +62% to 51.4K (+63% prior).</li>\n<li>CC at  4:30PM ET (<a href=\"http://www.yelp-ir.com/phoenix.zhtml?p=irol-eventDetails&amp;c=250809&amp;eventID=4980834\" target=\"_blank\">webcast</a>)</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1180942\" target=\"_blank\">Q2 results</a>, PR, <a href=\"http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTk1MjczfENoaWxkSUQ9LTF8VHlwZT0z&amp;t=1\" target=\"_blank\">earnings slides</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1181162\" data-linked=\"Yelp&#39;s Q3/2013 guidance strong, shares +5% AH\" data-tweet=\"$YELP - Yelp&#39;s Q3/2013 guidance strong, shares +5% AH https://seekingalpha.com/news/1181162-yelps-q3-2013-guidance-strong-shares-plus-5-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1181162-yelps-q3-2013-guidance-strong-shares-plus-5-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181102\" data-ts=\"1375301901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181102-more-on-whole-foods-markets-fq3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Whole Foods Market&#39;s FQ3</a></h4><ul>     <li>Comparable store sales rose 7.5% during the quarter while gross profit increased 61 bps to 36.6% as a percentage of total sales.</li>\n<li>The development pipeline is now up to 94 leases and \"accelerating\" square footage growth is expected for several more years.</li>\n<li>Whole Foods Market (WFM) sees full-year EPS of $1.45-$1.46 vs. $1.45 consensus. (PR)</li>     <li>WFM <font color=\"red\">-0.4%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181102\" data-linked=\"More on Whole Foods Market&#39;s FQ3\" data-tweet=\"$AMZN - More on Whole Foods Market&#39;s FQ3 https://seekingalpha.com/news/1181102-more-on-whole-foods-markets-fq3?source=tweet\" data-url=\"https://seekingalpha.com/news/1181102-more-on-whole-foods-markets-fq3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181082\" data-ts=\"1375301876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWA\" target=\"_blank\">DWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181082-dreamworks-rises-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DreamWorks rises on earnings beat</a></h4><ul>     <li>DreamWorks (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DWA\" title=\"Dreamworks Animation SKG Inc\">DWA</a>) <a href=\"https://seekingalpha.com/currents/post/1180862\" target=\"_blank\">beats</a> on the top and bottom line for Q2. Revenue rises 31% Y/Y.</li>     <li>Shares <font color=\"green\">+6.62%</font> AH.</li>     <li>\n<em>The Croods</em> \"incredibly successful box office run\" contributes $71.8M in revenue for the period.</li>     <li>CEO Jeffrey Katzenberg emphasizes diversification, saying DWA has \"a great deal of momentum within [the] television, consumer products and location-based entertainment businesses.\"</li>     <li>Q3 results will be driven by \"worldwide pay television revenue for <em>Rise of the Guardians</em> and international free television for <em>Kung Fu Panda 2</em>.\" (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181082\" data-linked=\"DreamWorks rises on earnings beat\" data-tweet=\"$DWA - DreamWorks rises on earnings beat https://seekingalpha.com/news/1181082-dreamworks-rises-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1181082-dreamworks-rises-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181072\" data-ts=\"1375301777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRN\" target=\"_blank\">TRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181072-trinity-industries-beats-by-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trinity Industries beats by $0.11, beats on revenue</a></h4><ul>     <li>Trinity Industries (NYSE:<a href=\"https://seekingalpha.com/symbol/TRN\" title=\"Trinity Industries Inc.\">TRN</a>): Q2 EPS of $1.06 <font color=\"green\">beats by $0.11</font>.</li>\n<li>Revenue of $1.1B (+7% Y/Y) <font color=\"green\">beats by $0.08B</font>. Shares  <font color=\"green\">+2.3%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1181072\" data-linked=\"Trinity Industries beats by $0.11, beats on revenue\" data-tweet=\"$TRN - Trinity Industries beats by $0.11, beats on revenue https://seekingalpha.com/news/1181072-trinity-industries-beats-by-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1181072-trinity-industries-beats-by-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1181012\" data-ts=\"1375301592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1181012-sunpower-eps-beats-by-0_37-revenue-misses-by-3m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunPower EPS beats by $0.37, revenue misses by $3M</a></h4><ul>     <li>SunPower (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a>): Q2 EPS of $0.48 <font color=\"green\">beats by $0.37</font>.</li>     <li>Revenue of $576.5M (-3% Y/Y) <font color=\"red\">misses by $3M</font>.</li>\n<li>Expects Q3 revenue of $550M-$600M and EPS of $0.15-$0.35 vs. a consensus of $682.2M and $0.19.</li>\n<li>Expects 2013 revenue of $2.5B-$2.6B and EPS of $1-$1.30 vs. a consensus of $2.57B and $0.77.</li>\n<li>Shares  <font color=\"green\">+3.3%</font> AH. (PR)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1181012\" data-linked=\"SunPower EPS beats by $0.37, revenue misses by $3M\" data-tweet=\"$SPWR - SunPower EPS beats by $0.37, revenue misses by $3M https://seekingalpha.com/news/1181012-sunpower-eps-beats-by-0_37-revenue-misses-by-3m?source=tweet\" data-url=\"https://seekingalpha.com/news/1181012-sunpower-eps-beats-by-0_37-revenue-misses-by-3m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180952\" data-ts=\"1375301504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYD\" target=\"_blank\">BYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180952-boyd-gaming-announces-a-15m-share-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boyd Gaming announces a 15M share secondary offering</a></h4><ul>\n<li>Boyd Gaming (NYSE:<a href=\"https://seekingalpha.com/symbol/BYD\" title=\"Boyd Gaming Corporation\">BYD</a>) announces a 15M share secondary offering, with a 30-day option for underwriters to purchase up to an additional 2,250,000 shares for over allotments if needed.</li>\n<li>The Company intends to use the net proceeds to redeem a portion of the its 7.125% Senior Subordinated Notes due 2016 and for general corporate purposes.</li>\n<li>Deutsche Bank and JPMorgan are acting as joint book-runners.</li>\n<li>Shares <font color=\"red\">-6.2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180952\" data-linked=\"Boyd Gaming announces a 15M share secondary offering\" data-tweet=\"$BYD - Boyd Gaming announces a 15M share secondary offering https://seekingalpha.com/news/1180952-boyd-gaming-announces-a-15m-share-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1180952-boyd-gaming-announces-a-15m-share-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180942\" data-ts=\"1375301430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180942-yelp-beats-by-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp beats by $0.03, beats on revenue</a></h4><ul>     <li>Yelp (NYSE:<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a>): Q2 EPS of -$0.01 <font color=\"green\">beats by $0.03</font>.</li>\n<li>Revenue of $55M (+69% Y/Y) <font color=\"green\">beats by $1.7M</font>. Shares  <font color=\"green\">+3.7%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180942\" data-linked=\"Yelp beats by $0.03, beats on revenue\" data-tweet=\"$YELP - Yelp beats by $0.03, beats on revenue https://seekingalpha.com/news/1180942-yelp-beats-by-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1180942-yelp-beats-by-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180852\" data-ts=\"1375301119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180852-j-c-penneys-credit-issues-in-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney&#39;s credit issues in focus</a></h4><ul>     <li>Retail Sails is out with a <a href=\"https://twitter.com/retail_sails/status/362663215466942464\" target=\"_blank\">quick response</a> to <i>The New York Post</i> story indicating J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) is having <a href=\"https://seekingalpha.com/currents/post/1180752\" target=\"_blank\">credit issues</a>. The research firm says its sources tip off the retailer is still receiving factoring services from firms other than CIT.</li>     <li>JCP <font color='green'>+0.7%</font> AH after a 10.2% drop on the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180852\" data-linked=\"J.C. Penney&#39;s credit issues in focus\" data-tweet=\"$JCP - J.C. Penney&#39;s credit issues in focus https://seekingalpha.com/news/1180852-j-c-penneys-credit-issues-in-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/1180852-j-c-penneys-credit-issues-in-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180782\" data-ts=\"1375300680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUN\" target=\"_blank\">SUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180782-susser-petroleum-partners-started-with-buy-at-benchmark\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susser Petroleum Partners started with Buy at Benchmark</a></h4><ul>     <li>Susser Petroleum Partners (SUSP <font color=\"green\">+1.9%</font>) is initiated with a <a href=\"http://www.streetinsider.com/New+Coverage/Benchmark+Starts+Susser+Petroleum+Partners+LP+%28SUSP%29+at+Buy/8549928.html\" target=\"_blank\">Buy rating</a> and a $35 price target at Benchmark, seeing upside potential given SUSP's growth and operating margin opportunities.</li>     <li>Given steady profitability and management's consistent execution, the firm believes shares are not trading at their full value.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180782\" data-linked=\"Susser Petroleum Partners started with Buy at Benchmark\" data-tweet=\"$SUN - Susser Petroleum Partners started with Buy at Benchmark https://seekingalpha.com/news/1180782-susser-petroleum-partners-started-with-buy-at-benchmark?source=tweet\" data-url=\"https://seekingalpha.com/news/1180782-susser-petroleum-partners-started-with-buy-at-benchmark\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180772\" data-ts=\"1375300330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BXC\" target=\"_blank\">BXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180772-bluelinx-takes-a-hit-on-widening-net-losses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlueLinx takes a hit on widening net losses</a></h4><ul><li>BlueLinx (<a href='https://seekingalpha.com/symbol/BXC' title='BlueLinx Holdings, Inc.'>BXC</a> <font color='red'>-9.8%</font>) takes a hit today as Q2 net losses widened significantly. (<a href=\"http://archive.fast-edgar.com/20130731/Aabs-tmnav-dE-6iczGP-p-g-4-2BNl-o/\" target=\"_blank\">10-Q</a>)</li><li>Q2 revenues increased 16.9% to $604.6M from $517M for the same period a year ago, but the company incurred a net loss of $22.3M, or $0.27 per diluted share.</li><li>This compares with a net loss of $3.7M, or $0.06 per diluted share, for Q212.</li></ul><div class=\"tiny-share-widget\" data-id=\"1180772\" data-linked=\"BlueLinx takes a hit on widening net losses\" data-tweet=\"$BXC - BlueLinx takes a hit on widening net losses https://seekingalpha.com/news/1180772-bluelinx-takes-a-hit-on-widening-net-losses?source=tweet\" data-url=\"https://seekingalpha.com/news/1180772-bluelinx-takes-a-hit-on-widening-net-losses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180752\" data-ts=\"1375300094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180752-j-c-penney-tanks-on-new-credit-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney tanks on new credit concerns</a></h4><ul>     <li>Shares of J.C. Penney (<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a> <font color=\"red\">-9.5%</font>) nosedive after <i>The New York Post</i> reports the retailer is having <a href=\"http://www.nypost.com/p/news/business/jcpenney_is_having_credit_problems_SCqAJhSlOyeFUuabaTdPDJ\" target=\"_blank\">more credit problems.</a>\n</li>     <li>Sources indicate commercial lender CIT has stopped supporting deliveries from small manufacturers to J.C. Penney stores on credit fears.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1180752\" data-linked=\"J.C. Penney tanks on new credit concerns\" data-tweet=\"$JCP - J.C. Penney tanks on new credit concerns https://seekingalpha.com/news/1180752-j-c-penney-tanks-on-new-credit-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/1180752-j-c-penney-tanks-on-new-credit-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180742\" data-ts=\"1375300017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVLN\" target=\"_blank\">NVLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180742-aegerion-higher-again-on-juxtapid-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegerion higher again on Juxtapid outlook</a></h4><ul>\n<li>All aboard the Aegerion (AEGR <font color=\"green\">+10.4%</font>) train! The company's upbeat outlook for <a href=\"https://seekingalpha.com/currents/post/1173952\" target=\"_blank\">Juxtapid sales</a> has the stock moving sharply higher again today.</li>\n<li>Jefferies (Buy) raises the price target on the shares to $92 from $82 noting accelerating weekly scripts data. Analyst Eun Yang also says \"&lt;10% dropout rate and ~7% gross-to-net discount are encouraging.\"</li>\n<li>Tip of the hat to SA Pro contributor Cory Renauer who penned a <a href=\"https://seekingalpha.com/article/1495942-why-aegerion-is-worth-1-732-times-sales\" target=\"_blank\">bullish Juxtapid piece</a> back on June 12 \u2014 that was some 25% ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180742\" data-linked=\"Aegerion higher again on Juxtapid outlook\" data-tweet=\"$NVLN $NVLNF - Aegerion higher again on Juxtapid outlook https://seekingalpha.com/news/1180742-aegerion-higher-again-on-juxtapid-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1180742-aegerion-higher-again-on-juxtapid-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180722\" data-ts=\"1375299585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180722-gold-erases-loss-following-fomc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold erases loss following FOMC</a></h4><ul>     <li>Down nearly 2% and flirting with falling below $1,300 per ounce, <a href=\"http://finviz.com/futures_charts.ashx?t=GC&amp;p=m5\" target=\"_blank\">gold bounces</a> to slightly in the green following the <a href=\"https://seekingalpha.com/currents/post/1180452\" target=\"_blank\">FOMC policy statement </a>more concerned with slowing growth, rising interest rates, and slowing inflation than with tapering QE purchases.</li>     <li><a href='https://seekingalpha.com/symbol/gld' title='SPDR Gold Trust ETF'>GLD</a> <font color='red'>-0.1%</font>, <a href='https://seekingalpha.com/symbol/iau' title='iShares Gold Trust ETF'>IAU</a> <font color='red'>-0.2%</font>.</li>     <li>Silver reverses course as well.</li>     <li><a href='https://seekingalpha.com/symbol/slv' title='iShares Silver Trust ETF'>SLV</a><font color='green'> +0.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180722\" data-linked=\"Gold erases loss following FOMC\" data-tweet=\"$GLD $IAU $SLV - Gold erases loss following FOMC https://seekingalpha.com/news/1180722-gold-erases-loss-following-fomc?source=tweet\" data-url=\"https://seekingalpha.com/news/1180722-gold-erases-loss-following-fomc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180702\" data-ts=\"1375299207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180702-hess-seeking-partners-for-assets-in-kurdistan-ghana\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hess seeking partners for assets in Kurdistan, Ghana</a></h4><ul>     <li>Hess (<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a> <font color=\"green\">+2.2%</font>) says in its <a href=\"https://seekingalpha.com/article/1589342-hess-management-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a> it is <a href=\"http://www.reuters.com/article/2013/07/31/us-hess-results-idUSBRE96U10Z20130731\" target=\"_blank\">seeking partners</a> to explore two fields in Iraq's Kurdistan and a block offshore Ghana, as it looks to add to the $3.5B in assets already sold this year and helping send shares higher today.</li>     <li>Expects higher production in H2 from North Dakota's Bakken shale due to the transition to pad drilling, in which more wells are sunk from a single spot.</li>\n<li>Says it is <a href=\"http://www.csnews.com/top-story-real_estate-hess_says_it_s__premature__to_share_any_retail_selloff_details_-64180.html\" target=\"_blank\">continuing efforts to sell its retail division</a> but provides no details; plans to spin off its midstream Bakken assets into an MLP in 2015.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180702\" data-linked=\"Hess seeking partners for assets in Kurdistan, Ghana\" data-tweet=\"$HES - Hess seeking partners for assets in Kurdistan, Ghana https://seekingalpha.com/news/1180702-hess-seeking-partners-for-assets-in-kurdistan-ghana?source=tweet\" data-url=\"https://seekingalpha.com/news/1180702-hess-seeking-partners-for-assets-in-kurdistan-ghana\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180682\" data-ts=\"1375299067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUVA\" target=\"_blank\">NUVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180682-nuvasive-slides-on-subpoena-concerns-and-a-challenging-market-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuvasive slides on subpoena concerns and a challenging market outlook</a></h4><ul>\n<li>NuVasive (<a href=\"https://seekingalpha.com/symbol/NUVA\" title=\"NuVasive, Inc.\">NUVA</a> <font color=\"red\">-13.6%</font>) slides today as news of a federal subpoena casts uncertainty over the maker of spinal medical devices.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/NUVA\" title=\"NuVasive, Inc.\">NUVA</a> beat the Street's <a href=\"https://seekingalpha.com/market_currents/post/1176262\" target=\"_blank\">Q2 revenue estimates</a>, but the company disclosed late yesterday <a href=\"http://www.sec.gov/Archives/edgar/data/1142596/000114259613000007/nuva-6x30x2013x10xq.htm\" target=\"_blank\">a \"broad\" subpoena</a> by Medicare and Medicaid's IG office regarding potentially false claims.</li>\n<li>SA contributor Stephen Simpson says that although the subpoena puts blood in the water for the shorts, the company <a href=\"https://seekingalpha.com/article/1590342-in-line-doesnt-cut-it-for-nuvasive?source=google_news\" target=\"_blank\">faces bigger challenges</a> from a competitive pricing environment, which could stymie ambitious growth plans.</li>\n<li>Canaccord agrees, saying that <a href=\"https://seekingalpha.com/symbol/NUVA\" title=\"NuVasive, Inc.\">NUVA</a> has overcome salesforce churn and heavier competition, but <a href=\"http://futures.tradingcharts.com/news/futures/DJ_MARKET_TALK__NuVasive_Falls_With_Uncertainty_Over_Subpoena_201481019.html\" target=\"_blank\">still has to prove itself</a> in a tough environment for health-care companies.</li>\n<li>Barclays adds that the company remains challenged by \"difficult spine-market dynamics,\" as well as other factors.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180682\" data-linked=\"Nuvasive slides on subpoena concerns and a challenging market outlook\" data-tweet=\"$NUVA - Nuvasive slides on subpoena concerns and a challenging market outlook https://seekingalpha.com/news/1180682-nuvasive-slides-on-subpoena-concerns-and-a-challenging-market-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1180682-nuvasive-slides-on-subpoena-concerns-and-a-challenging-market-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180582\" data-ts=\"1375297131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180582-cytori-rises-on-puregraft-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytori rises on Puregraft sale</a></h4><ul>\n<li>Cytori Therapeutics (<a href=\"https://seekingalpha.com/symbol/CYTX\" title=\"Cytori Therapeutics Inc\">CYTX</a> <font color=\"green\">+6.4%</font>) jumps after the company sells the       global manufacturing and commercialization rights for Puregraft to Bimini Technologies for $5M upfront and up to $10M in milestone payments tied to sales of the fat grafting product.</li>\n<li>Bimini has also acquired the commercialization rights to the Celution System       for Alopecia.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180582\" data-linked=\"Cytori rises on Puregraft sale\" data-tweet=\"$CYTX $PSTV - Cytori rises on Puregraft sale https://seekingalpha.com/news/1180582-cytori-rises-on-puregraft-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/1180582-cytori-rises-on-puregraft-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180572\" data-ts=\"1375296907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CENX\" target=\"_blank\">CENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180572-century-aluminum-sinks-15-percent-after-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Century Aluminum sinks 15% after Q2 results</a></h4><ul>     <li>Century Aluminum (<a href=\"https://seekingalpha.com/symbol/CENX\" title=\"Century Aluminum Company\">CENX</a> <font color=\"red\">-15%</font>) sinks in the wake of <a href=\"https://seekingalpha.com/currents/post/1176082\" target=\"_blank\">Q2 results</a> and worries over weak demand and the potential impact of proposed LME warehousing changes.</li>     <li>J.P. Morgan <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3800495/update-j-p-morgan-lowers-pt-on-century-aluminum-on-updat\" target=\"_blank\">cuts its price target</a> on CENX to $8.50 from $9, noting that \"while the new power rates  would improve Century's current cost structure... we do not expect they will be correlated with primary LME aluminum prices, which merits a discount given the potential for margin volatility absent any hedging.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180572\" data-linked=\"Century Aluminum sinks 15% after Q2 results\" data-tweet=\"$CENX - Century Aluminum sinks 15% after Q2 results https://seekingalpha.com/news/1180572-century-aluminum-sinks-15-percent-after-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1180572-century-aluminum-sinks-15-percent-after-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180552\" data-ts=\"1375296603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMED\" target=\"_blank\">AMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180552-amedisys-gains-on-a-solid-q2-eps-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amedisys gains on a solid Q2 EPS report</a></h4><ul><li>Amedisys (<a href='https://seekingalpha.com/symbol/AMED' title='AMEDISYS Inc'>AMED</a> <font color='green'>+8.4%</font>) moves up after its <a href=\"https://seekingalpha.com/market_currents/post/1178172\" target=\"_blank\">Q2 EPS easily topped forecasts</a> this morning, largely due to lower operating expenses.</li><li>Net income actually declined 38% from the same quarter last year.</li><li>Net service revenue fell 13.7% over the same period.</li><li>For FY13, the company expects to report diluted earnings in the range of $0.45 to $0.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"1180552\" data-linked=\"Amedisys gains on a solid Q2 EPS report\" data-tweet=\"$AMED - Amedisys gains on a solid Q2 EPS report https://seekingalpha.com/news/1180552-amedisys-gains-on-a-solid-q2-eps-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1180552-amedisys-gains-on-a-solid-q2-eps-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180512\" data-ts=\"1375296072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180512-cummins-quarter-impresses-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cummins&#39; quarter impresses Goldman</a></h4><ul>\n<li>Goldman's Jerry Revich <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Maintains+CL-Buy+on+Cummins+%28CMI%29/8551179.html\" target=\"_blank\">reiterates a Conviction List-Buy</a> on shares of Cummins (<a href=\"https://seekingalpha.com/symbol/CMI\" title=\"Cummins Inc.\">CMI</a> <font color=\"green\">+2.6%</font>) following the company's <a href=\"https://seekingalpha.com/currents/post/1173892\" target=\"_blank\">Q2 results</a>.</li>\n<li>Revich highlights \"a $1B new product cycle in CMI's highest margin business\" next year, which should \"drive significant upside to consensus.\"</li>\n<li>Other positives include \"meaningfully higher Engine profitability despite continued mix headwinds, a high returns  Distribution acquisition, and improving Power Generation cost control.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180512\" data-linked=\"Cummins&#39; quarter impresses Goldman\" data-tweet=\"$CMI - Cummins&#39; quarter impresses Goldman https://seekingalpha.com/news/1180512-cummins-quarter-impresses-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/1180512-cummins-quarter-impresses-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180492\" data-ts=\"1375295847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOS\" target=\"_blank\">BIOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180492-bioscrip-announces-new-credit-facilities-and-results-of-its-tender-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioScrip announces new credit facilities and results of its tender offer</a></h4><ul>\n<li>BioScrip (<a href=\"https://seekingalpha.com/symbol/BIOS\" title=\"BioScrip, Inc.\">BIOS</a> <font color=\"green\">+2.1%</font>) says it's arranged new credit facilities, in part to finance its acquisition of CarePoint Partners and to buy back outstanding notes.</li>\n<li>The company has entered into a senior secured first-lien revolving credit facility worth $75M, plus a senior secured first-lien term loan B for $250M and a senior secured first-lien delayed draw term loan B for $150M.</li>\n<li>The company also says it's received and accepted for purchase approximately $126.2M of its outstanding notes under its tender offer.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180492\" data-linked=\"BioScrip announces new credit facilities and results of its tender offer\" data-tweet=\"$BIOS - BioScrip announces new credit facilities and results of its tender offer https://seekingalpha.com/news/1180492-bioscrip-announces-new-credit-facilities-and-results-of-its-tender-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/1180492-bioscrip-announces-new-credit-facilities-and-results-of-its-tender-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180472\" data-ts=\"1375295672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSX\" target=\"_blank\">PSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180472-phillips-66-snaps-back-as-investors-re-evaluate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phillips 66 snaps back as investors re-evaluate</a></h4><ul>     <li>Phillips 66 (<a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"green\">+4.8%</font>) bounces back from an initial negative reaction to <a href=\"https://seekingalpha.com/currents/post/1179232\" target=\"_blank\">Q2 results</a> as investors realize that, other than production interruptions at its chemicals units, PSX continues to <a href=\"https://seekingalpha.com/article/1588812-phillips-66s-q2-a-miss-but-stock-is-worth-considering\" target=\"_blank\">operate its businesses very well</a>.</li>     <li>In the <a href=\"https://seekingalpha.com/article/1589702-phillips-66s-ceo-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, CEO Greg Garland said his biggest Q2 disappointment was a second power outage at the Sweeny refinery, adding that the power company was the cause of both outages.</li>     <li>PSX says it has <a href=\"http://www.reuters.com/article/2013/07/31/phillips66-results-crude-idUSL1N0G11520130731\" target=\"_blank\">increased runs of light crude imports</a> at its New Jersey refinery as costs of Bakken crude increased in recent weeks.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180472\" data-linked=\"Phillips 66 snaps back as investors re-evaluate\" data-tweet=\"$PSX - Phillips 66 snaps back as investors re-evaluate https://seekingalpha.com/news/1180472-phillips-66-snaps-back-as-investors-re-evaluate?source=tweet\" data-url=\"https://seekingalpha.com/news/1180472-phillips-66-snaps-back-as-investors-re-evaluate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180442\" data-ts=\"1375294895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180442-uralkali-could-discuss-joint-swiss-trading-firm-with-belarus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uralkali could discuss joint Swiss trading firm with Belarus</a></h4><ul>     <li>Although some analysts <a href=\"http://blogs.wsj.com/canadarealtime/2013/07/31/potash-miners-stocks-lose-more-ground\" target=\"_blank\">hold out hope</a> that potash producers Uralkali and Belaruskali can settle their differences and reverse the damage from <a href=\"https://seekingalpha.com/currents/post/1172672\" target=\"_blank\">yesterday's breakup</a>, Uralkali's CEO says <a href=\"http://www.reuters.com/article/2013/07/31/us-russia-uralkali-belarus-idUSBRE96U0WS20130731\" target=\"_blank\">it's not happening</a> although he could consider joining with Belarus in a Swiss-based trading company.</li>     <li>He believes new global potash projects will be delayed, and sees global potash demand rising to 59M-60M tons in 2014 from  54M-55M tons in 2013.</li>     <li>Separately, Potash (POT <font color=\"red\">-4.9%</font>) confirms the Toronto Stock Exchange's approval of a previously announced ~43.35M share repurchase program.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"red\">-2.8%</font>, <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"red\">-7.4%</font>, AGU <font color=\"red\">-2.1%</font>, <a href=\"https://seekingalpha.com/symbol/SQM\" title=\"Chemical &amp; Mining Co. of Chile Inc.\">SQM</a> <font color=\"red\">-4.9%</font>, <a href=\"https://seekingalpha.com/symbol/CF\" title=\"CF Industries Holdings, Inc.\">CF</a> <font color=\"red\">-0.5%</font>, <a href=\"https://seekingalpha.com/symbol/RNF\" title=\"Rentech Nitrogen Partners, L.P.\">RNF</a> <font color=\"red\">-1%</font>, <a href=\"https://seekingalpha.com/symbol/TNH\" title=\"Terra Nitrogen Co. LP\">TNH</a> <font color=\"red\">-1.3%</font>, <a href=\"https://seekingalpha.com/symbol/UAN\" title=\"CVR Partners, LP\">UAN</a> <font color=\"red\">-0.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180442\" data-linked=\"Uralkali could discuss joint Swiss trading firm with Belarus\" data-tweet=\"$NTR $NTR $MOS - Uralkali could discuss joint Swiss trading firm with Belarus https://seekingalpha.com/news/1180442-uralkali-could-discuss-joint-swiss-trading-firm-with-belarus?source=tweet\" data-url=\"https://seekingalpha.com/news/1180442-uralkali-could-discuss-joint-swiss-trading-firm-with-belarus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180372\" data-ts=\"1375293861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180372-concerns-over-caesars-entertainments-debt-load\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concerns over Caesars Entertainment&#39;s debt load</a></h4><ul>     <li>Shares of Caesars Entertainment (<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='red'>-7.5%</font>) fall with <a href=\"http://www.thedeal.com/content/restructuring/caesars-entertainment-plummets-toward-ch-11.php\" target=\"_blank\">more talk</a> that the company is heading toward a Chapter 11 bankruptcy filing.</li>     <li>According to one dour-sounding hedge fund manager, Caesars Entertainment needs \"a meteor to destroy the earth\" or a big name like Apollo Global Management to come in and buy billions of debt to avert bankruptcy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180372\" data-linked=\"Concerns over Caesars Entertainment&#39;s debt load\" data-tweet=\"$CZR - Concerns over Caesars Entertainment&#39;s debt load https://seekingalpha.com/news/1180372-concerns-over-caesars-entertainments-debt-load?source=tweet\" data-url=\"https://seekingalpha.com/news/1180372-concerns-over-caesars-entertainments-debt-load\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180362\" data-ts=\"1375293748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CW\" target=\"_blank\">CW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180362-curtis-wright-lands-contract-to-provide-flight-data-recording-system-to-irkut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Curtis-Wright lands contract to provide flight data recording system to Irkut</a></h4><ul>\n<li>Curtiss-Wright (<a href=\"https://seekingalpha.com/symbol/CW\" title=\"Curtiss-Wright Corporation\">CW</a> <font color=\"green\">+0.7%</font>) moves up today after saying it will supply the flight data recording system for use on the MC-21 aircraft program to Irkut Corporation.</li>\n<li>The contract has an initial value of $21M and an estimated future value in excess of $50M.</li>\n<li>Shipment is scheduled to begin in February, 2015.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180362\" data-linked=\"Curtis-Wright lands contract to provide flight data recording system to Irkut\" data-tweet=\"$CW - Curtis-Wright lands contract to provide flight data recording system to Irkut https://seekingalpha.com/news/1180362-curtis-wright-lands-contract-to-provide-flight-data-recording-system-to-irkut?source=tweet\" data-url=\"https://seekingalpha.com/news/1180362-curtis-wright-lands-contract-to-provide-flight-data-recording-system-to-irkut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180312\" data-ts=\"1375292691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IAC\" target=\"_blank\">IAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180312-interactivecorp-investors-take-profits-after-q2-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterActiveCorp investors take profits after Q2 beat</a></h4><ul>\n<li>Though InterActiveCorp's (IACI <font color=\"red\">-7%</font>) Q2 results beat expectations, investors are taking profits following <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1374868800000&amp;chddm=48682&amp;chls=IntervalBasedLine&amp;q=NASDAQ:IACI&amp;ntsp=0&amp;ei=4En5UYjzOsmfiQL68wE\" target=\"_blank\">a strong rally</a> from the Internet mini-conglomerate's January lows.</li>\n<li>Slumping margins might be worrying some investors. IAC's Q2 op. margin was 13.3%, down from 14.3% a year ago. A key reason: IAC's Local and Media units, which include video site Vimeo (seeing \"strong growth\"), local ad platform CityGrid (seeing declining revenue), and the <a href=\"https://seekingalpha.com/currents/post/1051921\" target=\"_blank\">struggling</a> Newsweek Daily Beast JV, saw a combined $8M op. loss vs. a $4.4M op. profit a year ago.</li>\n<li>The Search &amp; Applications division (53% of revenue, includes Ask.com) performed well: sales +23% Y/Y (+13% exc. the <a href=\"https://seekingalpha.com/currents/post/507481\" target=\"_blank\">About.com purchase</a>) and op. income +21% to $89.3M.</li>\n<li>Match division (online dating) sales +9%; op. income +2% to $58.4M.</li>\n<li>$73.1M was spent on buybacks.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1177152\" target=\"_blank\">Q2 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180312\" data-linked=\"InterActiveCorp investors take profits after Q2 beat\" data-tweet=\"$IAC - InterActiveCorp investors take profits after Q2 beat https://seekingalpha.com/news/1180312-interactivecorp-investors-take-profits-after-q2-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1180312-interactivecorp-investors-take-profits-after-q2-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180292\" data-ts=\"1375292274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180292-piper-jaffray-downgrades-trius-therapeutics-on-the-back-of-its-acquisition-by-cubist\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray downgrades Trius Therapeutics on the back of its Acquisition by Cubist</a></h4><ul>\n<li>Piper Jaffray weighs in on Trius Therapeutics (<a href=\"https://seekingalpha.com/symbol/TSRX\" title=\"\">TSRX</a> <font color=\"green\">+16.6%</font>), <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3800291/update-piper-jaffray-downgrades-trius-therapeutics-follo\" target=\"_blank\">cutting the shares</a> to Neutral from Overwieght on the back of the <a href=\"https://seekingalpha.com/market_currents/post/1176442\" target=\"_blank\">acquisition announcement</a> from Cubist (CBST).</li>\n<li>Cubist (CBST) will pay $13.50 in cash plus one non-tradeable $2.00 contingent value right for <a href=\"https://seekingalpha.com/symbol/TSRX\" title=\"\">TSRX</a>.</li>\n<li>Under the terms of the deal, <a href=\"https://seekingalpha.com/symbol/TSRX\" title=\"\">TSRX</a> shareholders will receive $1 if net tedizolid sales in the U.S., Canada and Europe reach $125M in 2016 and up to another $1 paid on a pro rata basis for the next $10M in 2016 net sales up to $135M.</li>\n<li>Piper forecasts 2016 tedizolid sales of $188M, so its sees a good chance that the full $2  CVR will be paid out.</li>\n<li>That being said, after applying an 18% discount rate back through today, Piper arrives at present CVR value of $1.32, leaving the stock near fair value.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180292\" data-linked=\"Piper Jaffray downgrades Trius Therapeutics on the back of its Acquisition by Cubist\" data-tweet=\"$MRK - Piper Jaffray downgrades Trius Therapeutics on the back of its Acquisition by Cubist https://seekingalpha.com/news/1180292-piper-jaffray-downgrades-trius-therapeutics-on-the-back-of-its-acquisition-by-cubist?source=tweet\" data-url=\"https://seekingalpha.com/news/1180292-piper-jaffray-downgrades-trius-therapeutics-on-the-back-of-its-acquisition-by-cubist\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180272\" data-ts=\"1375290895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REMX\" target=\"_blank\">REMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180272-rare-metals-etf-in-focus-after-report-of-spiking-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rare metals ETF in focus after report of spiking prices</a></h4><ul>\n<li>Do you know what's in your ETF? The Market Vectors Rare Earth/Strategic Metals ETF (<a href=\"https://seekingalpha.com/symbol/REMX\" title=\"VanEck Vectors Rare Earth/Strategic Metals ETF\">REMX</a> <font color=\"green\">+0.6%</font>) shows little reaction to <a href=\"https://seekingalpha.com/currents/post/1180192\" target=\"_blank\">spiking rare earth stocks</a> amid a report on skying prices in China.</li>\n<li>Of the rare earth stocks moving higher, only Molycorp is in the ETF's top 10 holdings, a 5.87% stake.</li>\n<li>The ETF underwent a 1:4 reverse split at the start of July amid poor performance taking the price down to single digits.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180272\" data-linked=\"Rare metals ETF in focus after report of spiking prices\" data-tweet=\"$REMX - Rare metals ETF in focus after report of spiking prices https://seekingalpha.com/news/1180272-rare-metals-etf-in-focus-after-report-of-spiking-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/1180272-rare-metals-etf-in-focus-after-report-of-spiking-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180262\" data-ts=\"1375290462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180262-invivo-therapeutics-tumbles-on-up-listing-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo Therapeutics tumbles on up-listing delay</a></h4><ul><li>Shares of InVivo Therapeutics (<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-17%</font>) plummet after the company says plans to up-list to a national securities exchange have \"been <a href=\"https://twitter.com/JNapodano/status/362328634586959872/photo/1\" target=\"_blank\">postponed indefinitely</a> due to issues related to corporate governance.\"</li><li>SA contributor and Zacks analyst <a href=\"https://seekingalpha.com/author/jason-napodano?source=search_general&amp;s=jason-napodano\" target=\"_blank\">Jason Napodano</a> says the company <a href=\"http://www.twitlonger.com/show/n_1rllqnc\" target=\"_blank\">wouldn't disclose</a> to him the nature of the issues but did say that it was a minor delay.</li></ul><div class=\"tiny-share-widget\" data-id=\"1180262\" data-linked=\"InVivo Therapeutics tumbles on up-listing delay\" data-tweet=\"$NVIV - InVivo Therapeutics tumbles on up-listing delay https://seekingalpha.com/news/1180262-invivo-therapeutics-tumbles-on-up-listing-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/1180262-invivo-therapeutics-tumbles-on-up-listing-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180242\" data-ts=\"1375290189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTO\" target=\"_blank\">MKTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180242-marketo-plus-21-percent-on-q2-revenue-beat-q3-2013-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marketo +21% on Q2 revenue beat, Q3/2013 guidance</a></h4><ul>     <li>The volatile cloud marketing automation software firm is making new post-IPO highs after posting mixed Q2 results and issuing strong top-line guidance.</li>     <li>Marketo's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a>) Q3 guidance is for revenue of $23M-$24M and EPS of -$0.23 to -$0.26 vs. a consensus of $20.9M and -$0.24.</li>     <li>2013 guidance is for revenue of $89M-$91M and EPS of -$1.38 to -$1.50 vs. a consensus of $83.1M and -$1.47.</li>     <li>Deferred revenue - a closely-watched figure for cloud software companies, who recognize only a portion of subscription payments up-front - jumped 25% Q/Q and 81% Y/Y to $30.6M.</li>     <li>CEO Phillip Fernandez stated on the CC Marketo \"[continues] to see great strength in the Salesforce.com ecosystem,\" as well as for other platforms such as Microsoft Dynamics. Shares <a href=\"https://seekingalpha.com/currents/post/1063031\" target=\"_blank\">tumbled in June</a> on worries about the Salesforce/ExactTarget deal.</li>     <li>Shares <strong><font color=\"green\">+143%</font></strong> from a May IPO price of $13.</li>     <li>Rival Responsys (<a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a> <font color=\"green\">+2.4%</font>), which reports on Aug. 5, is up in sympathy.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1176252\" target=\"_blank\">Q2 results</a>, PR, <a href=\"https://seekingalpha.com/article/1587182-marketos-ceo-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">CC transcript</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1180242\" data-linked=\"Marketo +21% on Q2 revenue beat, Q3/2013 guidance\" data-tweet=\"$MKTO $MKTO $MKTG - Marketo +21% on Q2 revenue beat, Q3/2013 guidance https://seekingalpha.com/news/1180242-marketo-plus-21-percent-on-q2-revenue-beat-q3-2013-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1180242-marketo-plus-21-percent-on-q2-revenue-beat-q3-2013-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180232\" data-ts=\"1375290185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BEAT\" target=\"_blank\">BEAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180232-cardionet-jumps-on-solid-q2-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardionet jumps on solid Q2 earnings beat</a></h4><ul>\n<li>CardioNet (<a href=\"https://seekingalpha.com/symbol/BEAT\" title=\"BioTelemetry, Inc.\">BEAT</a> <font color=\"green\">+32%</font>) soars after its <a href=\"https://seekingalpha.com/market_currents/post/1177642\" target=\"_blank\">Q2 easily beat estimates</a> across the board.</li>\n<li>Adjusted EPS turned to a profit from a prior year Q2 loss for the first time in four years.</li>\n<li>Serviced record patient volume for the second consecutive quarter.</li>\n<li>The company benefited from the acquisition of Cardiocore in Q312, which enabled it to post strong gains in its research services business both year over year and sequentially.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180232\" data-linked=\"Cardionet jumps on solid Q2 earnings beat\" data-tweet=\"$BEAT - Cardionet jumps on solid Q2 earnings beat https://seekingalpha.com/news/1180232-cardionet-jumps-on-solid-q2-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1180232-cardionet-jumps-on-solid-q2-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180212\" data-ts=\"1375290084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFL\" target=\"_blank\">AFL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180212-new-52-week-high-for-aflac\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New 52-week high for Aflac</a></h4><ul>\n<li>Aflac (<a href=\"https://seekingalpha.com/symbol/AFL\" title=\"Aflac Incorporated\">AFL</a> <font color=\"green\">+1.8%</font>) hits a new 52-week high today after <a href=\"https://seekingalpha.com/currents/post/1175962\" target=\"_blank\">last night's earnings</a>.</li>\n<li>On the earnings call (<a href=\"https://seekingalpha.com/article/1589192-aflacs-ceo-discusses-q2-2013-results-earnings-call-transcript?source=email_rt_article_title\" target=\"_blank\">transcript</a>), management makes note of its expanded alliance with Japan Post, increasing over time from 1K to 20K the number of post office outlets in which Aflac's cancer products will be offered.</li>\n<li>It's a \"game-changer,\" says Aflac Japan Chairman Charles Lake (who also took to CNBC saying the same thing). Japan Post is the largest insurer in the world with over $1T in assets and none of its 79 agencies have ever sold for Aflac.</li>\n<li>For now, forward guidance on 3rd party sales does not include any contribution from the Japan Post deal.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180212\" data-linked=\"New 52-week high for Aflac\" data-tweet=\"$AFL - New 52-week high for Aflac https://seekingalpha.com/news/1180212-new-52-week-high-for-aflac?source=tweet\" data-url=\"https://seekingalpha.com/news/1180212-new-52-week-high-for-aflac\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180192\" data-ts=\"1375289594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180192-molycorp-spikes-on-report-of-strength-in-rare-earth-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp spikes on report of strength in rare earth prices</a></h4><ul>     <li>A spike in Molycorp (MCP <font color=\"green\">+6.7%</font>) is attributed to an article that says China rare earth prices <a href=\"http://agmetalminer.com/2013/07/30/china-rare-earths-prices-skyrocket-molycorp-lynas-sittin-pretty/\" target=\"_blank\">skyrocketed</a> in the past week.</li>     <li>Dysprosium oxide jumped 79% in the past week, according to <em>MetalMiner</em>'s price index; yttria climbed 47%, terbium rose 34.5%.</li>     <li>Briefing.com note: MCP shares have a 38% short interest as of July 15.</li>     <li>Other rare earth names: <a href=\"https://seekingalpha.com/symbol/REE\" title=\"Rare Element Resources Ltd.\">REE</a>, <a href=\"https://seekingalpha.com/symbol/SHZ\" title=\"China Shen Zhou Mining &amp; Resources, Inc\">SHZ</a>, <a href=\"https://seekingalpha.com/symbol/AVL\" title=\"Avalon Rare Metals Inc.\">AVL</a>, <a href=\"https://seekingalpha.com/symbol/GSM\" title=\"Ferroglobe PLC\">GSM</a>, <a href=\"https://seekingalpha.com/symbol/LYSCF\" title=\"Lynas Corp. Ltd.\">OTCPK:LYSCF</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180192\" data-linked=\"Molycorp spikes on report of strength in rare earth prices\" data-tweet=\"$MCPIQ $MCPIQ $REE - Molycorp spikes on report of strength in rare earth prices https://seekingalpha.com/news/1180192-molycorp-spikes-on-report-of-strength-in-rare-earth-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/1180192-molycorp-spikes-on-report-of-strength-in-rare-earth-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180182\" data-ts=\"1375289134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180182-midday-top-10-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Top 10 gainers / losers</a></h4><b>Top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/BEAT' title='BioTelemetry, Inc.'>BEAT</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color='green'>+30%</font>. QCOR <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/HXM' title='Desarrolladora Homex, S.A.B. de C.V. &#40;Homex&#41;'>HXM</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/MKTO' title='Marketo'>MKTO</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/EDGW' title='Edgewater Technology, Inc.'>EDGW</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PSTR' title='PostRock Energy Corporation'>OTC:PSTR</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/TSRX' title=''>TSRX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/HNSN' title='Hansen Medical, Inc.'>HNSN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/RELV' title='Reliv&#39; International, Inc.'>RELV</a> <font color='green'>+17%</font>. <br /><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/MERU' title='Meru Networks, Inc.'>MERU</a> <font color='red'>-24%</font>. PBIB <font color='red'>-22%</font>. VTNC <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/JIVE' title='Jive Software'>JIVE</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='red'>-18%</font>. URRE <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/HSON' title='Hudson Global, Inc'>HSON</a> <font color='red'>-16%</font>. USU <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/IRG' title='Ignite Restaurant Group'>IRG</a> <font color='red'>-13%</font>.<div class=\"tiny-share-widget\" data-id=\"1180182\" data-linked=\"Midday Top 10 gainers / losers\" data-tweet=\"$BEAT $EHTH $MNK - Midday Top 10 gainers / losers https://seekingalpha.com/news/1180182-midday-top-10-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1180182-midday-top-10-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180162\" data-ts=\"1375288534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALR\" target=\"_blank\">ALR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180162-alere-ramps-higher-on-solid-q2-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alere ramps higher on solid Q2 earnings beat</a></h4><ul>\n<li>Alere (<a href=\"https://seekingalpha.com/symbol/ALR\" title=\"Alere Inc.\">ALR</a> <font color=\"green\">+11%</font>) sets a new 52-week high today after posting better-than-expected <a href=\"https://seekingalpha.com/market_currents/post/1178502\" target=\"_blank\">Q2 earnings</a>.</li>\n<li>Total revenue grew by 9% Y/Y, driven in part by the currency adjusted organic growth rate for its professional diagnostics segment, which rose 8.6%, excluding changes in U.S. Triage and influenza revenues.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180162\" data-linked=\"Alere ramps higher on solid Q2 earnings beat\" data-tweet=\"$ALR - Alere ramps higher on solid Q2 earnings beat https://seekingalpha.com/news/1180162-alere-ramps-higher-on-solid-q2-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1180162-alere-ramps-higher-on-solid-q2-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180152\" data-ts=\"1375288255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180152-vanda-slips-after-earnings-feuerstein-questions-milestone-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda slips after earnings, Feuerstein questions milestone payment</a></h4><ul>\n<li>Vanda Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> <font color=\"red\">-2.7%</font>) takes a break after gaining 44% Tuesday on FDA <a href=\"https://seekingalpha.com/currents/post/1173732\" target=\"_blank\">acceptance of an NDA</a> for <a href=\"https://seekingalpha.com/currents/search?query=tasimelteon\" target=\"_blank\">tasimelteon</a>. Earlier, the company reported a <a href=\"https://seekingalpha.com/currents/post/1178042\" target=\"_blank\">narrower Q2 loss</a> than the Street expected.</li>\n<li>It's not surprising to see investors taking some off the table today, but worth mentioning as a possible explanation for weakness is a piece by Adam Feuerstein (a tasimelteon <a href=\"https://seekingalpha.com/currents/post/1093192\" target=\"_blank\">critic</a>) which calls the company's $500K milestone payment (a material financial event) to an unnamed outside consultant \"<a href=\"http://www.thestreet.com/story/11994676/1/vanda-fda-and-500k-bonus-paid-to-a-mystery-regulatory-consultant.html\" target=\"_blank\">weird</a>.\"</li>\n<li>It's not the enlistment of a hired gun to help tasimelteon's regulatory chances that's strange, Feuerstein notes. It's the fact that he (or she) was paid \"just because the FDA accepted [a] drug filing\" an event which is \"a routine and expected occurrence.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180152\" data-linked=\"Vanda slips after earnings, Feuerstein questions milestone payment\" data-tweet=\"$VNDA - Vanda slips after earnings, Feuerstein questions milestone payment https://seekingalpha.com/news/1180152-vanda-slips-after-earnings-feuerstein-questions-milestone-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/1180152-vanda-slips-after-earnings-feuerstein-questions-milestone-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180132\" data-ts=\"1375287851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BVN\" target=\"_blank\">BVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180132-buenaventuras-q2-profits-plunges-88-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buenaventura&#39;s Q2 profits plunges 88%</a></h4><ul>     <li>It was an <a href=\"http://www.reuters.com/article/2013/07/31/peru-buenaventura-earnings-idUSL1N0G10TU20130731\" target=\"_blank\">ugly quarter</a> for top Peruvian miner Buenaventura (<a href=\"https://seekingalpha.com/symbol/BVN\" title=\"Compañía de Minas Buenaventura S.A.A.\">BVN</a> <font color=\"red\">-2.6%</font>): an 88% drop in net income, production from mines it owns directly fell 65%, and sales fell 18% because of lower prices for gold, silver and copper. (<a href=\"http://finance.yahoo.com/news/buenaventura-announces-second-quarter-six-020800170.html\" target=\"_blank\">H1 and Q2 results</a>)</li>     <li>JPMorgan analyst John Bridges, however, is <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/07/31/buenaventura-falling-gold-prices-claim-another-victim\" target=\"_blank\">still optimistic</a>, as BVN continues to generate free cash flows, is optimistic it can still achieve its 2013 gold and silver production guidance, and pays dividends. He recommends buying shares on weakness.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180132\" data-linked=\"Buenaventura&#39;s Q2 profits plunges 88%\" data-tweet=\"$BVN - Buenaventura&#39;s Q2 profits plunges 88% https://seekingalpha.com/news/1180132-buenaventuras-q2-profits-plunges-88-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1180132-buenaventuras-q2-profits-plunges-88-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180122\" data-ts=\"1375287818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNW\" target=\"_blank\">GNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180122-genworth-remains-cheap-but-without-a-catalyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genworth remains cheap, but without a catalyst</a></h4><ul>\n<li>BTIG's Mark Palmer <a href=\"http://www.btigresearch.com/create-pdf/?url_pdf=wp-content/uploads/2013/07/Genworth-Financial-2Q13.pdf&amp;name_pdf=Genworth-Financial-2Q13&amp;id=33392\" target=\"_blank\">reiterates his Neutral </a>rating on Genworth (<a href=\"https://seekingalpha.com/symbol/GNW\" title=\"Genworth Financial, Inc.\">GNW</a> <font color=\"red\">-1.9%</font>) as operating EPS of $0.27 missed his $0.30 estimate.</li>\n<li>While he continues to believe the company trades at a discount to its sum-of-its-parts value - the stock sells for 0.57x book (excluding AOCI) - Palmer isn't seeing any near-term catalysts to propel a higher share price.</li>\n<li>He notes the company's U.S. mortgage insurance unit chalked up its 2nd consecutive quarterly profit as delinquencies fell.</li>\n<li>Australian mortgage insurance income bounced back from Q1's slowing, maybe quelling concerns about that country's property market</li>\n<li>In another bubbly property market, Canadian mortgage insurance wracked up a $43M gain, up from $1M in Q1 as delinquencies fell.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1177222\" target=\"_blank\">Earnings report</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180122\" data-linked=\"Genworth remains cheap, but without a catalyst\" data-tweet=\"$GNW - Genworth remains cheap, but without a catalyst https://seekingalpha.com/news/1180122-genworth-remains-cheap-but-without-a-catalyst?source=tweet\" data-url=\"https://seekingalpha.com/news/1180122-genworth-remains-cheap-but-without-a-catalyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180112\" data-ts=\"1375287615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MX\" target=\"_blank\">MX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180112-magnachip-takes-off-thanks-to-q2-beat-100m-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagnaChip takes off thanks to Q2 beat, $100M buyback</a></h4><ul>\n<li>MagnaChip (<a href=\"https://seekingalpha.com/symbol/MX\" title=\"MagnaChip Semiconductor Corporation\">MX</a> <font color=\"green\">+16.2%</font>) is making new 52-week highs after soundly beating Q2 estimates and announcing a $100M buyback plan (good for repurchasing 12% of shares at current levels).</li>\n<li>The gains come even though the Korean chipmaker/foundry provider is guiding for Q3 revenue of $215M-$225M, below a $229.6M consensus. A likely reason: shares are still only trading at ~8x 2013E EPS. Also, some <a href=\"https://seekingalpha.com/currents/post/1166592\" target=\"_blank\">Samsung-related</a> weakness may have been priced in.</li>\n<li>A 20% Y/Y increase in foundry revenue (now 51% of total revenue) fueled the Q2 beat. Display chip sales -10%, power management chips +7%.</li>\n<li>Q2 gross margin was 33%, +100 bps Q/Q and +200 bps Y/Y. MagnaChip expects a Q3 GM of 33%-34%.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1175802\" target=\"_blank\">Q2 results</a>, PR, <a href=\"https://seekingalpha.com/article/1587292-magnachip-semiconductors-ceo-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">CC transcript</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180112\" data-linked=\"MagnaChip takes off thanks to Q2 beat, $100M buyback\" data-tweet=\"$MX - MagnaChip takes off thanks to Q2 beat, $100M buyback https://seekingalpha.com/news/1180112-magnachip-takes-off-thanks-to-q2-beat-100m-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/1180112-magnachip-takes-off-thanks-to-q2-beat-100m-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180102\" data-ts=\"1375287012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYNO\" target=\"_blank\">CYNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180102-cynosure-beats-on-q2-eps-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cynosure beats on Q2 EPS, revenue</a></h4><ul>\n<li>Cynosure (<a href=\"https://seekingalpha.com/symbol/CYNO\" title=\"Cynosure, Inc.\">CYNO</a> <font color=\"green\">+6.6%</font>) moves up today after reporting <a href=\"https://seekingalpha.com/market_currents/post/1178852\" target=\"_blank\">Q2 earnings</a> that beat Street estimates this morning.</li>\n<li>Revenue rose 27% Y/Y, reflecting higher laser product sales across its distribution channels as well as an additional $5.1M in revenue from five days of sales attributable to its Palomar acquisition.</li>\n<li>Operating expenses rose to $42.4M, which included $20.4M in acquisition expenses.</li>\n<li>The company noted that it expects to complete its integration of the Palomar acquisition over the next several quarters, with the acquisition still on pace to be accretive in FY14.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180102\" data-linked=\"Cynosure beats on Q2 EPS, revenue\" data-tweet=\"$CYNO - Cynosure beats on Q2 EPS, revenue https://seekingalpha.com/news/1180102-cynosure-beats-on-q2-eps-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1180102-cynosure-beats-on-q2-eps-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180092\" data-ts=\"1375286921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180092-ehealth-soars-on-deal-with-government\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">eHealth soars on deal with government</a></h4><ul>\n<li>eHealth (<a href=\"https://seekingalpha.com/symbol/EHTH\" title=\"eHealth, Inc.\">EHTH</a> <font color=\"green\">+27.4%</font>) moves sharply higher after a regulatory filing (<a href=\"http://www.sec.gov/Archives/edgar/data/1333493/000119312513311356/d573648d8k.htm\" target=\"_blank\">8-K</a>) reveals that the company has entered into an agreement with the Center for Medicare and Medicaid Services under which it will be able to access the FFE (created under Obamacare) database to determine prospective buyers' eligibility for subsidies.</li>\n<li>The deal is the first step toward EHTH \"being permitted to use its platform to enroll individuals into qualified health plans [and] assist individuals in applying for subsidies through the FFE.\"</li>\n<li>A \"person close to the matter\" tells CNBC full approval for EHTH to enroll customers is now just a \"<a href=\"http://www.cnbc.com/id/100925732\" target=\"_blank\">formality</a>.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180092\" data-linked=\"eHealth soars on deal with government\" data-tweet=\"$EHTH - eHealth soars on deal with government https://seekingalpha.com/news/1180092-ehealth-soars-on-deal-with-government?source=tweet\" data-url=\"https://seekingalpha.com/news/1180092-ehealth-soars-on-deal-with-government\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180082\" data-ts=\"1375286503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JEC\" target=\"_blank\">JEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180082-jacobs-engineering-gains-on-outlook-overcomes-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jacobs Engineering gains on outlook, overcomes downgrades</a></h4><ul>\n<li>Jacob Engineering (<a href=\"https://seekingalpha.com/symbol/JEC\" title=\"Jacobs Engineering Group Inc.\">JEC</a> <font color=\"green\">+2%</font>) trades higher today, flying in the face of downgrades by two firms following the company's <a href=\"https://seekingalpha.com/market_currents/post/1172792\" target=\"_blank\">Q3 earnings</a> results.</li>\n<li>FBR Capital Markets today <a href=\"http://www.streetinsider.com/Downgrades/FBR+Capital+Downgrades+Jacobs+Engineering+%28JEC%29+to+Market+Perform+on+Valuation/8549027.html\" target=\"_blank\">cut the stock</a> to Market Perform from Outperfrom on valuation with a price target of $63, down $5 from its previous view.</li>\n<li>Johnson Rice also <a href=\"http://www.streetinsider.com/Downgrades/Johnson+Rice+Downgrades+Jacobs+Engineering+%28JEC%29+to+Equalweight/8550207.html\" target=\"_blank\">lowers the company</a> to Equal Weight from Overweight.</li>\n<li>Yesterday, <a href=\"https://seekingalpha.com/symbol/JEC\" title=\"Jacobs Engineering Group Inc.\">JEC</a> reported Q3 net earnings of $0.83 per share, missing Street expectations by $0.02. However, the company offered an upbeat outlook for the remainder of the year, as well as an increase in its backlog of business, which grew by 10.2% to $17.2B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180082\" data-linked=\"Jacobs Engineering gains on outlook, overcomes downgrades\" data-tweet=\"$JEC $J - Jacobs Engineering gains on outlook, overcomes downgrades https://seekingalpha.com/news/1180082-jacobs-engineering-gains-on-outlook-overcomes-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/1180082-jacobs-engineering-gains-on-outlook-overcomes-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1180052\" data-ts=\"1375286111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YOKU\" target=\"_blank\">YOKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1180052-youku-rallies-following-baidu-stake-rumor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Youku rallies following Baidu stake rumor</a></h4><ul>\n<li>Youku (<a href=\"https://seekingalpha.com/symbol/YOKU\" title=\"Youku Tudou Inc.\">YOKU</a> <font color=\"green\">+4.5%</font>) shares have jumped thanks to <a href=\"https://twitter.com/thenotablecalls/status/362594706577821698\" target=\"_blank\">a rumor</a> Baidu (<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a> <font color=\"green\">+0.8%</font>) will take a stake in the Chinese online video leader (<a href=\"http://kuaixun.stcn.com/2013/0712/10599546.shtml\" target=\"_blank\">translation</a>).</li>\n<li>Like <a href=\"https://seekingalpha.com/currents/post/1032731\" target=\"_blank\">some other</a> Baidu-related rumors, this one should be taken with a grain of salt, given Baidu competes with Youku via its iQiyi and (<a href=\"https://seekingalpha.com/currents/post/1003271\" target=\"_blank\">recently-acquired</a>) PPS sites.</li>\n<li>The rumor comes shortly after Youku boasted its daily mobile video views topped 200M in June, up from <a href=\"https://seekingalpha.com/currents/post/1033091\" target=\"_blank\">170M in May</a> and 100M in January. Youku also claimed (citing iResearch data) it had 14M daily unique mobile visitors in June, well above iQiyi's 7M and PPS' 6.9M.</li>\n<li>Youku stated in May it had 100M+ monthly mobile users, and that mobile had grown to make up ~30% of its traffic.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1180052\" data-linked=\"Youku rallies following Baidu stake rumor\" data-tweet=\"$YOKU $YOKU $BIDU - Youku rallies following Baidu stake rumor https://seekingalpha.com/news/1180052-youku-rallies-following-baidu-stake-rumor?source=tweet\" data-url=\"https://seekingalpha.com/news/1180052-youku-rallies-following-baidu-stake-rumor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179962\" data-ts=\"1375285355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179962-marvell-makes-new-52-week-highs-on-chromecast-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell makes new 52-week highs on Chromecast buzz</a></h4><ul>     <li>Marvell (<a href=\"https://seekingalpha.com/symbol/MRVL\" title=\"Marvell Technology Group, Ltd.\">MRVL</a> <font color=\"green\">+2.3%</font>) shares are <font color=\"green\">up 8%</font> on the week, as investors react to <a href=\"https://seekingalpha.com/currents/post/1172542\" target=\"_blank\">glowing reviews</a> and <a href=\"https://seekingalpha.com/currents/post/1168812\" target=\"_blank\">strong early demand</a> for Google's $35 Chromecast HDMI streaming stick, which (as shown in <a href=\"http://www.slashgear.com/google-chromecast-gets-ifixit-teardown-treatment-26291924/\" target=\"_blank\">teardowns</a>) uses an ARM-based Marvell SoC.</li>     <li>Marvell has followed up by announcing a new SoC for Chromecast hardware.</li>     <li>Shares <strong><font color=\"green\">+80%</font></strong> YTD. David Einhorn must be happy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1179962\" data-linked=\"Marvell makes new 52-week highs on Chromecast buzz\" data-tweet=\"$MRVL - Marvell makes new 52-week highs on Chromecast buzz https://seekingalpha.com/news/1179962-marvell-makes-new-52-week-highs-on-chromecast-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/1179962-marvell-makes-new-52-week-highs-on-chromecast-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179922\" data-ts=\"1375284759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179922-fertilizer-stocks-extend-their-steep-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fertilizer stocks extend their steep slide</a></h4><ul>     <li>Fertilizer stocks <a href=\"http://www.marketwatch.com/story/mosaic-fertilizer-stocks-extend-steep-slide-2013-07-31\" target=\"_blank\">extend their steep slide</a> begun yesterday after Uralkali <a href=\"https://seekingalpha.com/currents/post/1172672\" target=\"_blank\">pulled out</a> of the cartel that controlled Russian exports: POT <font color=\"red\">-4.7%</font>, <a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"red\">-5.3%</font>, AGU <font color=\"red\">-2.7%</font>, <a href=\"https://seekingalpha.com/symbol/SQM\" title=\"Chemical &amp; Mining Co. of Chile Inc.\">SQM</a> <font color=\"red\">-7.2%</font>, <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"red\">-7.8%</font>.</li>     <li>Perhaps the players should have seen it coming, as \"<a href=\"http://247wallst.com/commodities-metals/2013/07/31/the-potash-scare-may-just-be-starting/\" target=\"_blank\">Russia is not a joiner</a>\" - the country\u2019s commodities producers have a long history of cutting prices to gain market share.</li>     <li>\"<a href=\"https://seekingalpha.com/currents/post/1173152\" target=\"_blank\">The end of the potash world as we know it</a>\" is <a href=\"http://business.financialpost.com/2013/07/30/potash-uralkali-prices/\" target=\"_blank\">not an exaggeration</a>, <em>FP</em>'s Peter Koven writes, as the move blows up the industry\u2019s entire oligopoly business model.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1179922\" data-linked=\"Fertilizer stocks extend their steep slide\" data-tweet=\"$NTR $NTR $MOS - Fertilizer stocks extend their steep slide https://seekingalpha.com/news/1179922-fertilizer-stocks-extend-their-steep-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1179922-fertilizer-stocks-extend-their-steep-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179932\" data-ts=\"1375284707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQR\" target=\"_blank\">EQR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179932-soft-guidance-hits-equity-residential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soft guidance hits Equity Residential</a></h4><ul>\n<li>In its Q2 <a href=\"https://seekingalpha.com/currents/post/1176332\" target=\"_blank\">earnings release</a>, Equity Residential (<a href=\"https://seekingalpha.com/symbol/EQR\" title=\"Equity Residential\">EQR</a> <font color=\"red\">-2.9%</font>) lowered the top end of FY13 normalized FFO guidance by a nickel to $2.80-$2.85/share as the midpoint of expense growth is expected at 3.25% vs. 3% a quarter ago.</li>\n<li>Management calls lower guidance the result of the company completing its $4B disposition program a year ahead of expectations.</li>\n<li>Occupancy expectations remain at 95.3% and the midpoint of revenue growth remains at 4.5%. (PR)</li>\n<li>CEO David Neithercut offers some nice color on the earnings call. Asked about the institutional rush into single-family housing rentals (about to be <a href=\"https://seekingalpha.com/currents/post/1176512\" target=\"_blank\">securitized</a>), he says the idea that single-family rentals can have the same operating margins as multifamily is \"just a joke.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1179932\" data-linked=\"Soft guidance hits Equity Residential\" data-tweet=\"$EQR - Soft guidance hits Equity Residential https://seekingalpha.com/news/1179932-soft-guidance-hits-equity-residential?source=tweet\" data-url=\"https://seekingalpha.com/news/1179932-soft-guidance-hits-equity-residential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179912\" data-ts=\"1375284506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179912-insys-gets-more-analyst-love-shares-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insys gets more analyst love, shares jump</a></h4><ul>\n<li>Wells Fargo starts Insys (<a href=\"https://seekingalpha.com/symbol/INSY\" title=\"Insys Therapeutics, Inc.\">INSY</a> <font color=\"green\">+5.9%</font>) at <a href=\"http://www.streetinsider.com/Analyst+Comments/Wells+Fargo+Starts+INSYS+Therapeutics+%28INSY%29+at+Outperform/8550177.html\" target=\"_blank\">Outperform</a> (PT $19-21). Oppenheimer also <a href=\"https://seekingalpha.com/currents/post/1179392\" target=\"_blank\">initiated coverage</a> today.</li>\n<li>Analyst Michael Faerm thinks Subsys \"is at the early stages of a multiyear organic growth ramp.\"</li>\n<li>The technology used in Subsys (a sublingual spray) \"can potentially be leveraged into longer term pipeline candidates.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1179912\" data-linked=\"Insys gets more analyst love, shares jump\" data-tweet=\"$INSY $INSYQ - Insys gets more analyst love, shares jump https://seekingalpha.com/news/1179912-insys-gets-more-analyst-love-shares-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/1179912-insys-gets-more-analyst-love-shares-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179902\" data-ts=\"1375284253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179902-astrazeneca-signs-collaboration-deal-with-fibrogen-to-develop-anemia-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca signs collaboration deal with Fibrogen to develop anemia drug</a></h4><ul>\n<li>AstraZeneca (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"green\">+0.9%</font>) inks a <a href=\"http://online.wsj.com/article/SB10001424127887324635904578639441536699494.html?mod=pls_whats_news_us_business_f\" target=\"_blank\">collaboration deal</a> to develop an oral anemia drug with privately held U.S. biotechnology company FibroGen that could potentially be worth more than $815M.</li>\n<li>The collaboration includes the development and commercialization of FG-4592, a drug that mimics the body's response to being at high altitude, which stimulates production of red blood cells and would be used to treat anemia.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a>'s is making an initial $350M payment to FibroGen, will could rise to as much as $815M if development milestones are reached, and possibly even exceed that with royalty payments on future sales in the low 20% range.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> has made $2.8B worth of acquisition and collaboration deals in the last six months alone in a bid to counteract the revenue-sapping effect of generic competition.</li>\n<li>The deal is limited to the U.S., China and a few other markets, but excludes Europe, Japan and other markets where FibroGen already has an agreement with Astellas Pharma (<a href=\"https://seekingalpha.com/symbol/ALPMY\" title=\"Astellas Pharma, Inc. ADR\">OTCPK:ALPMY</a>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1179902\" data-linked=\"AstraZeneca signs collaboration deal with Fibrogen to develop anemia drug\" data-tweet=\"$AZN $AZN $ALPMY - AstraZeneca signs collaboration deal with Fibrogen to develop anemia drug https://seekingalpha.com/news/1179902-astrazeneca-signs-collaboration-deal-with-fibrogen-to-develop-anemia-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/1179902-astrazeneca-signs-collaboration-deal-with-fibrogen-to-develop-anemia-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179892\" data-ts=\"1375284058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179892-new-52-week-highs-for-invensense-thanks-to-fq1-beat-fq2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New 52-week highs for InvenSense thanks to FQ1 beat, FQ2 guidance</a></h4><ul>\n<li>After reporting an <a href=\"https://seekingalpha.com/currents/post/1176542\" target=\"_blank\">FQ1 beat</a>, InvenSense (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"green\">+9.9%</font>) <a href=\"https://seekingalpha.com/article/1586652-invensense-management-discusses-q1-2014-results-earnings-call-transcript\" target=\"_blank\">guided on its CC</a> for FQ2 revenue of $68M-$70M and EPS of $0.19-$0.20, above a consensus of $66.3M and $0.18.</li>\n<li>CEO Behrooz Abdi mentioned InvenSense \"won several new designs\" for its 2-axis optical image stabilization <a href=\"http://www.invensense.com/mems/gyro/idg-ixz-202x.html\" target=\"_blank\">gyroscopes</a>, thanks to the adoption of SLR-like features in smartphones (likely a reference to Nokia's Lumia 1020 and/or Samsung's Galaxy S4 Zoom).</li>\n<li>He added InvenSense's signal processing/software features are increasingly a selling point, and boasted the company has 8K+ registered developers.</li>\n<li>Unsurprisingly, Apple (<a href=\"https://seekingalpha.com/currents/post/1112832\" target=\"_blank\">previous</a>) is never mentioned, but InvenSense says new design wins and share gains are responsible for its FQ2 forecast.</li>\n<li>Samsung was a \"high-20s\" customer in FQ1. But InvenSense says it has limited exposure to Samsung's high-end phones, whose sales have been <a href=\"https://seekingalpha.com/currents/post/1166592\" target=\"_blank\">pressured</a>.</li>\n<li>FQ1 gross margin was 52%, +200 bps Q/Q and -300 bps Y/Y. It's expected to come in at 52%-53% in FQ2.</li>\n<li>Opex +45% Y/Y in FQ1. Higher sales, R&amp;D, and (STMicroelectronics) litigation expenses were responsible.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1179892\" data-linked=\"New 52-week highs for InvenSense thanks to FQ1 beat, FQ2 guidance\" data-tweet=\"$INVN - New 52-week highs for InvenSense thanks to FQ1 beat, FQ2 guidance https://seekingalpha.com/news/1179892-new-52-week-highs-for-invensense-thanks-to-fq1-beat-fq2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1179892-new-52-week-highs-for-invensense-thanks-to-fq1-beat-fq2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179882\" data-ts=\"1375283691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179882-judge-swipes-mastercard-and-visa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Judge swipes MasterCard and Visa</a></h4><ul>     <li>Shares of Visa (<a href=\"https://seekingalpha.com/symbol/V\" title=\"Visa Inc.\">V</a> <font color=\"red\">-0.7%</font>) and MasterCard (<a href=\"https://seekingalpha.com/symbol/MA\" title=\"Mastercard, Inc.\">MA</a> <font color=\"green\">+2.3%</font>) fall lower after a U.S. judge <a href=\"http://about.bloomberglaw.com/legal-news/feds-debit-card-swipe-fee-rules-rejected-by-u-s-judge/\" target=\"_blank\">rules</a> the Federal Reserve doesn't have the authority to set a cap on debit-card transaction fees.</li>     <li>\"The Board has clearly disregarded Congress\u2019s statutory intent by inappropriately inflating all debit card transaction fees,\" reads Judge Richard Leon's ruling.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1179882\" data-linked=\"Judge swipes MasterCard and Visa\" data-tweet=\"$V $V $MA - Judge swipes MasterCard and Visa https://seekingalpha.com/news/1179882-judge-swipes-mastercard-and-visa?source=tweet\" data-url=\"https://seekingalpha.com/news/1179882-judge-swipes-mastercard-and-visa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179872\" data-ts=\"1375283564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179872-soros-takes-long-position-in-herbalife-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soros takes long position in Herbalife: CNBC</a></h4><ul><li>George Soros has taken a \"large\" long position in shares of Herbalife (<a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color='green'>+8.1%</font>), CNBC's Scott Wapner reports.</li><li>The position is supposedly one of Soros' largest.</li></ul><div class=\"tiny-share-widget\" data-id=\"1179872\" data-linked=\"Soros takes long position in Herbalife: CNBC\" data-tweet=\"$HLF - Soros takes long position in Herbalife: CNBC https://seekingalpha.com/news/1179872-soros-takes-long-position-in-herbalife-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/1179872-soros-takes-long-position-in-herbalife-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1179832\" data-ts=\"1375282576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSP\" target=\"_blank\">HSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1179832-hospira-jumps-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospira jumps on earnings beat</a></h4><ul>\n<li>Shares of Hospira (<a href=\"https://seekingalpha.com/symbol/HSP\" title=\"Hospira, Inc.\">HSP</a> <font color=\"green\">+2.4%</font>) rise in morning trading after the company beats analysts' bottom line expectations.</li>\n<li>Revenue comes in slightly lower versus Q2 2012 as price erosion on \"certain newer U.S. SIP products and lower device sales\" offset a strong performance from Precedex.</li>\n<li>Operating income rises 7.8% on a more favorable product mix compared to the year ago quarter.</li>\n<li>FY13 outlook: $2-2.10/ share (consensus is $2.03) on net sales growth of -1% to +1%. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1179832\" data-linked=\"Hospira jumps on earnings beat\" data-tweet=\"$HSP - Hospira jumps on earnings beat https://seekingalpha.com/news/1179832-hospira-jumps-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1179832-hospira-jumps-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}